Log in

ASX:RMD - RESMED/IDR UNRESTR Stock Price, Forecast & News

+0.06 (+0.27 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
Now: A$21.93
50-Day Range
MA: A$21.48
52-Week Range
Now: A$21.93
Volume555,461 shs
Average Volume1.82 million shs
Market Capitalization$31.53 billion
P/E Ratio75.62
Dividend Yield1.04%
ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. Read More…

Industry, Sector and Symbol

Industry Medical Instruments & Supplies



Sales & Book Value

Annual Sales$2.70 billion
Cash FlowA$0.12 per share
Book ValueA$1.47 per share



Outstanding Shares1,437,859,968
Market Cap$31.53 billion
Next Earnings DateN/A

Receive RMD News and Ratings via Email

Sign-up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.

RESMED/IDR UNRESTR (ASX:RMD) Frequently Asked Questions

What is RESMED/IDR UNRESTR's stock symbol?

RESMED/IDR UNRESTR trades on the ASX under the ticker symbol "RMD."

How often does RESMED/IDR UNRESTR pay dividends? What is the dividend yield for RESMED/IDR UNRESTR?

RESMED/IDR UNRESTR announced a interim dividend on Monday, October 28th. Investors of record on Thursday, December 12th will be given a dividend of 0.04 per share on Thursday, December 12th. This represents a yield of 0.19%. The ex-dividend date of this dividend is Wednesday, November 6th. This is a boost from RESMED/IDR UNRESTR's previous interim dividend of $0.04. View RESMED/IDR UNRESTR's Dividend History.

Has RESMED/IDR UNRESTR been receiving favorable news coverage?

Press coverage about RMD stock has been trending positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RESMED/IDR UNRESTR earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for RESMED/IDR UNRESTR.

Who are some of RESMED/IDR UNRESTR's key competitors?

What other stocks do shareholders of RESMED/IDR UNRESTR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RESMED/IDR UNRESTR investors own include CSL (CSL), Flight Centre Travel Group (FLT), Pro Medicus (PME), Primary Health Care (PRY), REA Group (REA), FuelCell Energy (FCEL), Western New England Bancorp (WNEB), Paycom Software (PAYC), Cochlear (COH) and Credit Corp Group (CCP).

Who are RESMED/IDR UNRESTR's key executives?

RESMED/IDR UNRESTR's management team includes the folowing people:
  • Mr. Michael J. Farrell BE, SM, MBA, CEO & Director (Age 47)
  • Mr. Robert A. Douglas, Pres & COO (Age 59)
  • Mr. Brett A. Sandercock, Chief Financial Officer (Age 52)
  • Mr. David B. Pendarvis, Chief Admin. Officer, Global Gen. Counsel & Sec. (Age 60)
  • Mr. James Hollingshead, Pres of Sleep Bus. (Age 56)

What is RESMED/IDR UNRESTR's stock price today?

One share of RMD stock can currently be purchased for approximately A$21.93.

How big of a company is RESMED/IDR UNRESTR?

RESMED/IDR UNRESTR has a market capitalization of $31.53 billion and generates $2.70 billion in revenue each year. RESMED/IDR UNRESTR employs 5,940 workers across the globe.View Additional Information About RESMED/IDR UNRESTR.

What is RESMED/IDR UNRESTR's official website?

The official website for RESMED/IDR UNRESTR is http://www.resmed.com/.

How can I contact RESMED/IDR UNRESTR?

RESMED/IDR UNRESTR's mailing address is 9001 Spectrum Center Blvd, SAN DIEGO, CA 92123-1438, United States. The company can be reached via phone at +1-858-7462400.

MarketBeat Community Rating for RESMED/IDR UNRESTR (ASX RMD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  161
MarketBeat's community ratings are surveys of what our community members think about RESMED/IDR UNRESTR and other stocks. Vote "Outperform" if you believe RMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel